About this trial
The project will study the impact of individually tailored lifestyle counselling compared to standard care on the parameters of NAFLD/NASH in patients with metabolic syndrome. The factors affecting the outcome (including clinical and laboratory parameters and microbiome profiling) will be evaluated.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Individuals with NAFLD and metabolic syndrome
Disqualifiers
Etiology of liver disease other than NAFLD.
Presence of malignant disease.
Uncontrolled cardiovascular disease
Pregnancy.
Trial design
Parallel
Treatments tested in this trial
Cognitive behavioral therapy
BehavioralSubjects will receive professional lifestyle intervention conducted by STOB organization. Using CBT and the so-called third wave of CBT, especially mindfulness, the patients will be guided by certified experts to increase motivation and to change eating and exercise habits, which will be mapped before and after the intervention.
Treatment groups
Trial outcomes
Primary outcomes
The effect of CBT on liver fat content
The effect of CBT on liver fat content measured by MRS (percentual change from baseline).
The effect of CBT on inflammatory parameters
The effect of CBT on inflammatory biochemical parameters (percentual change from baseline).
The effect of CBT on liver fibrosis
The effect of CBT on liver fibrosis measured by elastography (percentual change from baseline).
Sponsors and contacts
Click on the lead sponsor to view all of their trials.